a San Francisco, CA-based proteomics-focused biotech company, raised $5.2M in Seed funding.
The round was led by Artis Ventures, with participation from Pear VC, Page One Ventures, Civilization Ventures, Pillar, Four Cities Capital, Hawktail, and others. ARTIS Ventures Partner Ameena El-Bibany has joined the Board.
The company intends to use the funds to advance its work in high throughput multiplexed protein quantification to enable precision health.
Founded by former labmates Dr. Brandon Wilson and Dr. Nicolo Maganzini, and Professor Tom Soh from Stanford University, Range Biotechnologies is developing tools to unlock translational proteomics and enable personalized health. The technology allows for the accurate quantification of multiple proteins across many samples simultaneously, providing critical insights into the underlying mechanisms of disease and how they change over time.
The team is building a tech platform that will enable new modalities across multiple markets, including pharmacodynamics, diagnostic medicine, drug discovery, food safety, liquid biopsy, and more.